Hypersensitivity syndrome reaction to oral terbinafine
Authors:
- 1 August 1998
- journal article
- case report
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 39 (3) , 171-172
Abstract
SUMMARY: Terbinafine is used extensively to treat onychomycosis and other dermatomycoses. The case of a patient who developed a hypersensitivity syndrome reaction to oral terbinafine is discussed. A 66‐year‐old male was placed on terbinafine (250 mg/day) for the treatment of onychomycosis. After 4.5 weeks of therapy, the patient developed a cutaneous eruption, pyrexia, lymphadenopathy and hepatic dysfunction. No infectious or other cause was found for the symptoms and signs, which resolved within 6 weeks of stopping terbinafine. The patient had been on prednisone, doxazosin mesylate and aspirin for several months prior to starting terbinafine. These medications were continued during the episode and subsequently afterwards, with adjustment to the prednisone dosage only. The hypersensitivity syndrome reaction in this case involved multiple systems and was idiosyncratic in nature with no apparent predisposing factors. With the increasing use of oral terbinafine, it is likely that rare adverse events will occur more frequently. It is, therefore, important for physicians to be aware of the possible development of a hypersensitivity syndrome reaction in a patient on terbinafine who experiences an adverse event with multisystem involvement. Prompt recognition and determination of the extent of systemic involvement is important for the proper management of the patient.Keywords
This publication has 5 references indexed in Scilit:
- Terbinafine: An updateJournal of the American Academy of Dermatology, 1997
- Hypersensitivity reaction to terbinafineJournal of the American Academy of Dermatology, 1997
- Terbinafine therapy may be associated with the development of psoriasis de novo or its exacerbation: Four case reports and a review of drug-induced psoriasisJournal of the American Academy of Dermatology, 1997
- Antifungal agents: An overview. Part IIJournal of the American Academy of Dermatology, 1994
- Cutaneous drug reactionsCurrent Problems in Dermatology, 1994